Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000630680 | SCV000751645 | likely benign | not provided | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025383 | SCV004074616 | uncertain significance | not specified | 2023-09-06 | criteria provided, single submitter | clinical testing | The p.V347L variant (also known as c.1039G>T), located in coding exon 10 of the IKBKAP gene, results from a G to T substitution at nucleotide position 1039. The valine at codon 347 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001276242 | SCV001462248 | uncertain significance | Familial dysautonomia | 2020-01-17 | no assertion criteria provided | clinical testing |